|
OMIM |
Link |
Information gain |
01 |
|
PTH
|
[NCBI]
|
0.0128556
|
|
|
EPO
|
[NCBI]
|
0.00714634
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.00226097
|
|
|
MCKD1
|
[NCBI]
|
0.00171251
|
|
|
polycystic kidneys
|
[NCBI]
|
0.0015897
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00129953
|
|
|
VUR1
|
[NCBI]
|
0.000907667
|
|
|
SLE
|
[NCBI]
|
0.000750108
|
|
|
TKCR
|
[NCBI]
|
0.000641003
|
|
|
FMF
|
[NCBI]
|
0.00059565
|
|
|
cranioectodermal dysplasia
|
[NCBI]
|
0.000521852
|
|
|
fanconi renotubular syndrome
|
[NCBI]
|
0.000469717
|
|
|
VEGF
|
[NCBI]
|
0.000317114
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
0.000292795
|
|
|
ATD1
|
[NCBI]
|
0.000285016
|
|
|
acrorenal syndrome, autosomal recessive
|
[NCBI]
|
0.000275323
|
|
|
EGFR
|
[NCBI]
|
0.00026712
|
|
|
SLSN1
|
[NCBI]
|
0.000264924
|
|
|
CF
|
[NCBI]
|
0.000261572
|
|
|
CTNS
|
[NCBI]
|
0.000248433
|
|
|
NPHP1
|
[NCBI]
|
0.000241414
|
|
|
CEACAM5
|
[NCBI]
|
0.000239501
|
|
|
MCKD2
|
[NCBI]
|
0.000182796
|
|
|
TNF
|
[NCBI]
|
0.000174312
|
|
|
BBS
|
[NCBI]
|
0.000165313
|
|
|
EGF
|
[NCBI]
|
0.000161983
|
|
|
VDR
|
[NCBI]
|
0.000154835
|
|
|
raph blood group system
|
[NCBI]
|
0.000152598
|
|
|
denys-drash syndrome
|
[NCBI]
|
0.000150888
|
|
|
RA
|
[NCBI]
|
0.000146748
|
|
|
AFP
|
[NCBI]
|
0.000145632
|
|
|
papillorenal syndrome
|
[NCBI]
|
0.000144697
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
0.000141884
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
0.000138862
|
|
|
KLK3
|
[NCBI]
|
0.000136512
|
|
|
NPHP4
|
[NCBI]
|
0.000129116
|
|
|
ALB
|
[NCBI]
|
0.000125531
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
0.000122177
|
|
|
frasier syndrome
|
[NCBI]
|
0.000121813
|
|
|
LCAT
|
[NCBI]
|
0.000117745
|
|
|
nephrosialidosis
|
[NCBI]
|
0.000115891
|
|
|
APOE
|
[NCBI]
|
0.000111948
|
|
|
NPHP3
|
[NCBI]
|
0.00010661
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
0.00010661
|
|
|
NPHP2
|
[NCBI]
|
0.00010661
|
|
|
TH
|
[NCBI]
|
9.4451e-05
|
|
|
nephropathy, progressive tubulointerstitial, with cholestatic liver disease
|
[NCBI]
|
9.17223e-05
|
|
|
caroli disease, isolated
|
[NCBI]
|
9.17223e-05
|
|
|
nephropathy, deafness, and hyperparathyroidism
|
[NCBI]
|
9.17223e-05
|
|
|
marfanoid habitus with microcephaly and glomerulonephritis
|
[NCBI]
|
9.17223e-05
|
|
|
fabry disease
|
[NCBI]
|
8.99095e-05
|
|
|
NPPA
|
[NCBI]
|
8.96935e-05
|
|
|
aHUS
|
[NCBI]
|
8.78369e-05
|
|
|
CRH
|
[NCBI]
|
8.70588e-05
|
|
|
dent disease 1
|
[NCBI]
|
8.65634e-05
|
|
|
ACHE
|
[NCBI]
|
7.31761e-05
|
|
|
PCNA
|
[NCBI]
|
6.97122e-05
|
|
|
nephropathy with pretibial epidermolysis bullosa and deafness
|
[NCBI]
|
6.93062e-05
|
|
|
SLSN4
|
[NCBI]
|
6.93062e-05
|
|
|
glutamyl ribose-5-phosphate storage disease
|
[NCBI]
|
6.93062e-05
|
|
|
OFD1
|
[NCBI]
|
6.81668e-05
|
|
|
PKD1
|
[NCBI]
|
6.79725e-05
|
|
|
BGLAP
|
[NCBI]
|
6.44755e-05
|
|
|
CRC
|
[NCBI]
|
6.40845e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
6.37365e-05
|
|
|
ADIPOQ
|
[NCBI]
|
6.21916e-05
|
|
|
HNFJ
|
[NCBI]
|
6.19968e-05
|
|
|
hypomagnesemia, renal, with ocular involvement
|
[NCBI]
|
6.08806e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
6.08806e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
6.08806e-05
|
|
|
TBS
|
[NCBI]
|
5.93442e-05
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
5.54289e-05
|
|
|
ATS
|
[NCBI]
|
5.46838e-05
|
|
|
SLC22A6
|
[NCBI]
|
5.37826e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
5.13895e-05
|
|
|
FGF23
|
[NCBI]
|
4.87921e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
4.81819e-05
|
|
|
TS
|
[NCBI]
|
4.76791e-05
|
|
|
WT1
|
[NCBI]
|
4.6011e-05
|
|
|
CCL14
|
[NCBI]
|
4.56683e-05
|
|
|
MUC1
|
[NCBI]
|
4.55912e-05
|
|
|
XRN
|
[NCBI]
|
4.55241e-05
|
|
|
VIP
|
[NCBI]
|
4.49406e-05
|
|
|
CMH
|
[NCBI]
|
4.46628e-05
|
|
|
B2M
|
[NCBI]
|
4.40822e-05
|
|
|
FSGS1
|
[NCBI]
|
4.32569e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
4.2863e-05
|
|
|
TNFSF6
|
[NCBI]
|
4.17336e-05
|
|
|
CCK
|
[NCBI]
|
4.14055e-05
|
|
|
TG
|
[NCBI]
|
3.83126e-05
|
|
|
hypoparathyroidism, sensorineural deafness, and renal disease
|
[NCBI]
|
3.79663e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
3.79663e-05
|
|
|
RNASE3
|
[NCBI]
|
3.74678e-05
|
|
|
CAT
|
[NCBI]
|
3.72367e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
3.65472e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
3.52513e-05
|
|
|
BFH
|
[NCBI]
|
3.52513e-05
|
|
|
SHBG
|
[NCBI]
|
3.46404e-05
|
|
|
INHBA
|
[NCBI]
|
3.41034e-05
|
|
|
HOMG3
|
[NCBI]
|
3.40597e-05
|
|
|
CD2AP
|
[NCBI]
|
3.28305e-05
|
|
|
TNS1
|
[NCBI]
|
3.19885e-05
|
|
|
SOD3
|
[NCBI]
|
3.19885e-05
|
|
|
CLDN19
|
[NCBI]
|
3.19885e-05
|
|
|
TFPI
|
[NCBI]
|
3.118e-05
|
|
|
WT1
|
[NCBI]
|
3.06468e-05
|
|
|
amyloidosis v
|
[NCBI]
|
3.00776e-05
|
|
|
DRRS
|
[NCBI]
|
3.00776e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.9526e-05
|
|
|
PF4
|
[NCBI]
|
2.94176e-05
|
|
|
PPARA
|
[NCBI]
|
2.93141e-05
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
2.92332e-05
|
|
|
PXE
|
[NCBI]
|
2.8748e-05
|
|
|
RTD
|
[NCBI]
|
2.76819e-05
|
|
|
APC
|
[NCBI]
|
2.72975e-05
|
|
|
EPS
|
[NCBI]
|
2.69662e-05
|
|
|
AMBP
|
[NCBI]
|
2.68881e-05
|
|
|
RRM2B
|
[NCBI]
|
2.68881e-05
|
|
|
PAX2
|
[NCBI]
|
2.59147e-05
|
|
|
MPO
|
[NCBI]
|
2.56707e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
2.50182e-05
|
|
|
TTP
|
[NCBI]
|
2.44262e-05
|
|
|
MHA
|
[NCBI]
|
2.33152e-05
|
|
|
PRL
|
[NCBI]
|
2.32622e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
2.13398e-05
|
|
|
bsnd gene
|
[NCBI]
|
2.12005e-05
|
|
|
SLC22A8
|
[NCBI]
|
2.12005e-05
|
|
|
ACTN4
|
[NCBI]
|
2.12005e-05
|
|
|
SPP1
|
[NCBI]
|
1.96033e-05
|
|
|
NPHP3
|
[NCBI]
|
1.92999e-05
|
|
|
MPV17
|
[NCBI]
|
1.92999e-05
|
|
|
NPHP4
|
[NCBI]
|
1.92999e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
1.92344e-05
|
|
|
CADASIL
|
[NCBI]
|
1.88528e-05
|
|
|
GRHPR
|
[NCBI]
|
1.77363e-05
|
|
|
AVP
|
[NCBI]
|
1.73564e-05
|
|
|
CLDN16
|
[NCBI]
|
1.64124e-05
|
|
|
NPHP1
|
[NCBI]
|
1.52675e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
1.47635e-05
|
|
|
COMT
|
[NCBI]
|
1.44201e-05
|
|
|
CXORF5
|
[NCBI]
|
1.42617e-05
|
|
|
LPL
|
[NCBI]
|
1.26442e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.24006e-05
|
|
|
ARPKD
|
[NCBI]
|
1.24006e-05
|
|
|
GNRH1
|
[NCBI]
|
1.20757e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
1.18347e-05
|
|
|
TGFB1
|
[NCBI]
|
1.15578e-05
|
|
|
LIPC
|
[NCBI]
|
1.15578e-05
|
|
|
PKD2
|
[NCBI]
|
1.10232e-05
|
|
|
POMC
|
[NCBI]
|
1.10065e-05
|
|
|
NPS
|
[NCBI]
|
1.08402e-05
|
|
|
F3
|
[NCBI]
|
1.06143e-05
|
|
|
PKHD1
|
[NCBI]
|
9.99839e-06
|
|
|
porphyria variegata
|
[NCBI]
|
9.65921e-06
|
|
|
AHR
|
[NCBI]
|
9.5461e-06
|
|
|
LPI
|
[NCBI]
|
9.50252e-06
|
|
|
KL
|
[NCBI]
|
9.4777e-06
|
|
|
CTNS
|
[NCBI]
|
9.4777e-06
|
|
|
HGF
|
[NCBI]
|
9.12241e-06
|
|
|
CASR
|
[NCBI]
|
9.07635e-06
|
|
|
IL2
|
[NCBI]
|
8.79985e-06
|
|
|
LPA
|
[NCBI]
|
8.54208e-06
|
|
|
IL1A
|
[NCBI]
|
8.54208e-06
|
|
|
C4B
|
[NCBI]
|
8.54208e-06
|
|
|
MYH9
|
[NCBI]
|
7.72342e-06
|
|
|
ABCC1
|
[NCBI]
|
7.35093e-06
|
|
|
APRT
|
[NCBI]
|
7.21155e-06
|
|
|
ACE
|
[NCBI]
|
7.11973e-06
|
|
|
HNF1B
|
[NCBI]
|
6.99988e-06
|
|
|
XDH
|
[NCBI]
|
6.86496e-06
|
|
|
CTGF
|
[NCBI]
|
6.84193e-06
|
|
|
GIP
|
[NCBI]
|
6.77667e-06
|
|
|
APS1
|
[NCBI]
|
6.13111e-06
|
|
|
TF
|
[NCBI]
|
5.29882e-06
|
|
|
ACPP
|
[NCBI]
|
5.05833e-06
|
|
|
IL3
|
[NCBI]
|
5.01394e-06
|
|
|
ACP5
|
[NCBI]
|
4.81232e-06
|
|
|
COL4A5
|
[NCBI]
|
4.56383e-06
|
|
|
REN
|
[NCBI]
|
4.56383e-06
|
|
|
HRG
|
[NCBI]
|
4.56383e-06
|
|
|
MDD
|
[NCBI]
|
4.52719e-06
|
|
|
GHRH
|
[NCBI]
|
4.43679e-06
|
|
|
GSN
|
[NCBI]
|
4.35414e-06
|
|
|
ALK
|
[NCBI]
|
3.88245e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.88245e-06
|
|
|
GLA
|
[NCBI]
|
3.77944e-06
|
|
|
IAPP
|
[NCBI]
|
3.69962e-06
|
|
|
PLTP
|
[NCBI]
|
3.58387e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
3.43662e-06
|
|
|
UMOD
|
[NCBI]
|
3.43662e-06
|
|
|
TTR
|
[NCBI]
|
3.40192e-06
|
|
|
coproporphyria
|
[NCBI]
|
3.27601e-06
|
|
|
NPY
|
[NCBI]
|
3.13419e-06
|
|
|
EV
|
[NCBI]
|
2.57434e-06
|
|
|
DRPLA
|
[NCBI]
|
2.57434e-06
|
|
|
UGB
|
[NCBI]
|
2.56727e-06
|
|
|
wolman disease
|
[NCBI]
|
2.56727e-06
|
|
|
MMP9
|
[NCBI]
|
2.09687e-06
|
|
|
PCI
|
[NCBI]
|
2.09687e-06
|
|
|
AQP2
|
[NCBI]
|
1.99079e-06
|
|
|
NOS3
|
[NCBI]
|
1.88893e-06
|
|
|
LEP
|
[NCBI]
|
1.54708e-06
|
|
|
CCL2
|
[NCBI]
|
1.43748e-06
|
|
|
APOB
|
[NCBI]
|
1.35945e-06
|
|
|
AKR1B1
|
[NCBI]
|
1.33625e-06
|
|
|
LAM
|
[NCBI]
|
1.28784e-06
|
|
|
IDE
|
[NCBI]
|
1.07007e-06
|
|
|
SDC2
|
[NCBI]
|
1.00745e-06
|
|
|
TNFSF11
|
[NCBI]
|
1.00542e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.00542e-06
|
|
|
HP
|
[NCBI]
|
9.93872e-07
|
|
|
WBS
|
[NCBI]
|
9.57233e-07
|
|
|
MTR
|
[NCBI]
|
7.73138e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
7.73138e-07
|
|
|
PTHLH
|
[NCBI]
|
7.43175e-07
|
|
|
LBP
|
[NCBI]
|
7.21237e-07
|
|
|
CPB2
|
[NCBI]
|
6.71655e-07
|
|
|
MBL2
|
[NCBI]
|
6.315e-07
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
5.79171e-07
|
|
|
UCP2
|
[NCBI]
|
5.3614e-07
|
|
|
ASS
|
[NCBI]
|
5.3614e-07
|
|
|
SPINK1
|
[NCBI]
|
5.23177e-07
|
|
|
ADM
|
[NCBI]
|
4.45151e-07
|
|
|
AGER
|
[NCBI]
|
4.3788e-07
|
|
|
CVID
|
[NCBI]
|
2.84814e-07
|
|
|
von willebrand disease
|
[NCBI]
|
2.78354e-07
|
|
|
VHL
|
[NCBI]
|
2.61436e-07
|
|
|
MB
|
[NCBI]
|
2.38496e-07
|
|
|
IGFALS
|
[NCBI]
|
2.1025e-07
|
|
|
CP
|
[NCBI]
|
1.75345e-07
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.45162e-07
|
|
|
MFS
|
[NCBI]
|
1.26464e-07
|
|
|
ABP1
|
[NCBI]
|
1.06965e-07
|
|
|
BCHE
|
[NCBI]
|
9.3864e-08
|
|
|
SERPINA6
|
[NCBI]
|
8.56192e-09
|
|
|
ILK
|
[NCBI]
|
4.95591e-09
|
|
|
PON1
|
[NCBI]
|
4.95591e-09
|
|
|
CFH
|
[NCBI]
|
3.8459e-10
|
|